查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1576529

抗体生产市场：按产品、抗体、来源、製程 - 到 2031 年的全球预测

Antibody Production Market by Product, Antibody, Source, Process - Global Forecast to 2031
出版日期: | 出版商: Meticulous Research | 英文 200 Pages | 商品交期: 5-7个工作天内

价格

预计到 2031 年，抗体生产市场将达到 583.5 亿美元，2024 年至 2031 年的复合年增长率为 11.4%。在进行二次和初步研究并详细分析市场情景后，我们讨论了主要的行业推动因素、市场限制、市场机会、市场推动因素/课题和趋势。

抗体生产市场的成长是由对标靶抗体的需求增加、製药和生物技术公司研发投资增加、癌症和自体免疫疾病盛行率增加、免疫测定法使用增加以及製程技术进步所带来的推动。然而，抗体生产的高成本和严格的监管框架限制了市场的成长。

此外，抗体在临床试验和医学研究中的广泛使用、其在发展中国家的巨大潜力以及传染病风险和患病率的增加预计将为在该市场运营的公司提供成长机会。然而，单株抗体的复杂性给市场利害关係人带来了课题。

目录

第 1 章概述

第2章研究方法

第 3 章执行摘要

第 4 章市场洞察

  • 摘要
  • 市场成长因素
    • 市场动态
      • 促进因素
        • 对标靶抗体的需求不断增加
        • 製药和生技公司增加研发投资
        • 癌症和自体免疫疾病的负担沉重且盛行率不断上升
        • 增加免疫分析的使用
        • 生物製程技术的进步
      • 阻碍因素
        • 抗体生产成本高
        • 严格的监理框架
      • 机会
        • 扩大抗体在临床试验和医学研究的使用
        • 新兴国家的巨大机遇
        • 传染病的风险和传播增加
      • 课题
        • 单株抗体的复杂特性
  • 监理分析
  • 波特五力分析
  • 价格分析

第5章抗体生产市场评估：依产品

  • 摘要
  • 设备
    • 生物反应器
      • 可重复使用的生物反应器
      • 一次性生物反应器
    • 色谱系统
    • 过滤系统
    • 其他设备
  • 消耗品
    • 细胞株/培养基
    • 缓衝液/试剂
    • 色谱管/树脂
    • 其他消耗品
  • 软体

第6章抗体生产市场：以抗体类型评估

  • 摘要
  • 单株抗体
  • 多株抗体
  • 重组抗体

第7章抗体生产市场评估：依来源

  • 摘要
  • 滑鼠
  • 兔子
  • 其他来源

第 8 章抗体生产市场评估：依流程

  • 摘要
  • 下游流程
  • 上游流程

第 9 章抗体生产市场评估：依最终使用者

  • 摘要
  • 製药/生物公司
  • CRO□CDMO
  • 学术/研究机构

第10章抗体生产市场评估：依地区

  • 摘要
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他拉丁美洲地区
  • 中东/非洲

第11章竞争分析

  • 摘要
  • 主要成长策略
  • 竞争基准测试
  • 竞争对手仪表板
    • 行业领导者
    • 市场差异化因素
    • 前卫公司
    • 新兴公司
  • 主要企业市占率分析/市场排名（2022年）

第12章公司简介（业务概况、财务概况、产品组合、策略发展状况）

  • Thermo Fisher Scientific, Inc.
  • Merck KgaA
  • Eppendorf SE
  • Agilent Technologies, Inc.
  • Sartorius AG
  • Danaher Corporation
  • Waters Corporation
  • Shimadzu Corporation
  • Solaris Biotechnology Srl
  • Infors AG

（註：预定提供上位5公司之SWOT分析）

第13章 附录

Product Code: MRHC - 1041086

Antibody Production Market by Product [Bioreactors (Single-use, Reusable), Chromatography, Filtration, Cell Lines, Media, Buffers, Resins], Antibody [Monoclonal, Polyclonal], Source [Mice, Rabbit], Process [Downstream, Upstream] - Global Forecast to 2031

The antibody production market is projected to reach $58.35 billion by 2031, at a CAGR of 11.4% from 2024 to 2031. After secondary and primary research and an in-depth analysis of the market scenario, the report discusses key industry drivers, restraints, opportunities, challenges, and trends.

The growth of the antibody production market is driven by the growing demand for targeted antibodies, increasing investments in R&D by pharma & biotech companies, the growing prevalence of cancer and autoimmune diseases, the increasing use of immunoassays, and advancements in bioprocessing technologies. However, the high costs of antibody production and stringent regulatory frameworks restrain the growth of this market.

Furthermore, the growing applications of antibodies in clinical trials and medical research, significant potential in developing countries, and the growing risk and prevalence of infectious diseases are expected to generate growth opportunities for the players operating in this market. However, the complex nature of monoclonal antibodies is a challenge for market stakeholders.

Based on product, the antibody production market is segmented into instruments, consumables, and software. In 2024, the instruments segment is expected to account for the largest share of the antibody production market. The need for high-volume and scalable production of antibodies for commercial use, the need for separation, purification, and isolation of antibodies, and the growing need for mass production of antibodies for therapeutic applications are major factors contributing to the segment's large share.

Based on antibody type, the antibody production market is segmented into monoclonal antibodies, polyclonal antibodies, antibody segments, and recombinant antibodies. The monoclonal antibodies segment is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to the growing applications of monoclonal antibodies in the treatment of diseases and disorders, the growing use of monoclonal antibodies for cancer treatment, and the increasing focus of pharmaceutical & biotechnology companies on the development of monoclonal antibody-based therapeutics.

Based on source, the antibody production market is segmented into mice, rabbits, and other sources. In 2024, the mice segment is expected to account for the largest share of the antibody production market. Due to the availability, low cost, and quick production time for mouse mAbs, humanization of mouse mAbs has been implemented on a large scale. Furthermore, mouse husbandry is easier than rabbit husbandry, and the genetic approaches to engineering antibodies through recombinant technologies are more established for mice than for other animals, such as rabbits, making mice a preferred choice for antibody production.

Based on process, the antibody production market is segmented into upstream and downstream. In 2024, the downstream segment is expected to account for the larger share of the antibody production market. The segment's large share can be attributed to the high preference for downstream processing as it is used for the recovery and purification of biosynthetic products, including antibodies from natural sources such as animal or plant tissue or fermentation broth, including the recycling of salvageable components and the proper treatment and disposal of waste.

Based on end user, the antibody production market is segmented into pharmaceutical & biotechnology companies, clinical research organizations & contract development & manufacturing organizations, and other end users. The pharmaceutical & biotechnology companies segment is expected to grow at the highest CAGR during the forecast period. The growth of this segment is driven by the expansion of antibody manufacturing facilitates, increasing R&D investments by pharma & biotech companies, the growing prevalence of chronic & infectious diseases, and the need to develop antibody-based therapeutics for these diseases. In addition, initiatives by pharma and biotech companies to launch antibody-based therapeutics are further expected to drive the segment's growth.

An in-depth analysis of the geographical scenario in the antibody production market provides detailed qualitative and quantitative insights about five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2024, North America is expected to account for the largest share of the antibody production market, followed by Europe and Asia-Pacific. Technological advancements in bioprocessing, the high number of industry-academia collaborations for research & development of antibodies, the high prevalence of chronic diseases, and the high demand for biologics are expected to support North America's largest share.

The key companies operating in the antibody production market include Thermo Fisher Scientific Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Merck KgaA (Germany), Eppendorf SE (Germany), Sartorius AG (Germany), Danaher Corporation (U.S.), Waters Corporation (U.S.), Shimadzu Corporation (Japan), Solaris Biotechnology Srl (Italy), and Infors AG (Switzerland).

Scope of the Report:

Antibody Production Market Assessment-by Product

  • Instruments
    • Bioreactors
  • Single-use Bioreactors
  • Reusable Bioreactors
    • Chromatography Systems
    • Filtration Systems
    • Other Instruments

(Note: Other instruments include shakers, mixers, incubators, sterilizers, centrifuges, and bioprocessing containers.)

  • Consumables
    • Cell Lines & Media
    • Buffers & Reagents
    • Chromatography Columns & Resins
    • Other Consumables

(Note: Other consumables include membrane adsorbers, cell disruption reagents, pipettes, syringes, vials, closures, tubing, connectors, and sensors.)

  • Software

Antibody Production Market Assessment-by Antibody Type

  • Monoclonal Antibodies
  • Polyclonal Antibodies
  • Recombinant Antibodies

Antibody Production Market Assessment-by Source

  • Mice
  • Rabbits
  • Other Sources

(Note: Other sources include goats, sheep, and chicken.)

Antibody Production Market Assessment-by Process

  • Downstream
  • Upstream

Antibody Production Market Assessment-by End User

  • Pharmaceutical & Biotechnology Companies
  • Clinical Research Organizations & Contract Development & Manufacturing Organizations
  • Academic & Research Institutes

Antibody Production Market Assessment-by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • Japan
    • China
    • India
    • Rest of APAC (RoAPAC)
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America (RoLATAM)
  • Middle East & Africa

TABLE OF CONTENTS

1. Overview

  • 1.1. Market Definition & Scope
  • 1.2. Market Ecosystem
  • 1.3. Currency & Limitations
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Approach
  • 2.2. Process of Data Collection and Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research/Interviews with Key Opinion Leaders of The Industry
  • 2.3. Market Sizing and Forecast
    • 2.3.1. Market Size Estimation Approach
    • 2.3.2. Growth Forecast Approach
    • 2.3.3. Market Share Analysis
  • 2.4. Assumptions For the Study

3. Executive Summary

4. Market Insights

  • 4.1. Overview
  • 4.2. Factors Affecting Market Growth
    • 4.2.1. Market Dynamics
      • 4.2.1.1. Drivers
        • 4.2.1.1.1. Growing Demand for Targeted Antibodies
        • 4.2.1.1.2. Increasing Investments In R&D By Pharma & Biotech Companies
        • 4.2.1.1.3. High Burden and Growing Prevalence of Cancer and Autoimmune Diseases
        • 4.2.1.1.4. Increasing Use of Immunoassays
        • 4.2.1.1.5. Advancements In Bioprocessing Technologies
      • 4.2.1.2. Restraints
        • 4.2.1.2.1. High Cost of Antibody Production
        • 4.2.1.2.2. Stringent Regulatory Frameworks
      • 4.2.1.3. Opportunities
        • 4.2.1.3.1. Growing Applications of Antibodies in Clinical Trials and Medical Research
        • 4.2.1.3.2. Significant Opportunities from Developing Countries.
        • 4.2.1.3.3. Growing Risk and Prevalence of Infectious Diseases
      • 4.2.1.4. Challenges
        • 4.2.1.4.1. Complex Nature of Monoclonal Antibodies
  • 4.3. Regulatory Analysis
  • 4.4. Porter's Five Forces Analysis
  • 4.5. Pricing Analysis

5. Antibody Production Market Assessment-by Product

  • 5.1. Overview
  • 5.2. Instruments
    • 5.2.1. Bioreactors
      • 5.2.1.1. Reusable Bioreactors
      • 5.2.1.2. Single-use Bioreactors
    • 5.2.2. Chromatography Systems
    • 5.2.3. Filtration Systems
    • 5.2.4. Other Instruments
  • 5.3. Consumables
    • 5.3.1. Cell Lines & Media
    • 5.3.2. Buffers & Reagents
    • 5.3.3. Chromatography Columns & Resins
    • 5.3.4. Other Consumables
  • 5.4. Software

6. Antibody Production Market Assessment-by Antibody Type

  • 6.1. Overview
  • 6.2. Monoclonal Antibodies
  • 6.3. Polyclonal Antibodies
  • 6.4. Recombinant Antibodies

7. Antibody Production Market Assessment-by Source

  • 7.1. Overview
  • 7.2. Mice
  • 7.3. Rabbit
  • 7.4. Other Sources

8. Antibody Production Market Assessment-by Process

  • 8.1. Overview
  • 8.2. Downstream
  • 8.3. Upstream

9. Antibody Production Market Assessment-by End User

  • 9.1. Overview
  • 9.2. Pharmaceutical & Biotechnology Companies
  • 9.3. CROs & CDMOs
  • 9.4. Academic & Research Institutes

10. Antibody Production Market Assessment-by Geography

  • 10.1. Overview
  • 10.2. North America
    • 10.2.1. U.S.
    • 10.2.2. Canada
  • 10.3. Europe
    • 10.3.1. Germany
    • 10.3.2. France
    • 10.3.3. U.K.
    • 10.3.4. Italy
    • 10.3.5. Spain
    • 10.3.6. Rest of Europe
  • 10.4. Asia-Pacific
    • 10.4.1. China
    • 10.4.2. India
    • 10.4.3. Japan
    • 10.4.4. Rest of Asia-Pacific
  • 10.5. Latin America
    • 10.5.1. Brazil
    • 10.5.2. Mexico
    • 10.5.3. Rest of Latin America
  • 10.6. Middle East & Africa

11. Competition Analysis

  • 11.1. Overview
  • 11.2. Key Growth Strategies
  • 11.3. Competitive Benchmarking
  • 11.4. Competitive Dashboard
    • 11.4.1. Industry Leaders
    • 11.4.2. Market Differentiators
    • 11.4.3. Vanguards
    • 11.4.4. Emerging Companies
  • 11.5. Market Share Analysis/Market Ranking, by Key Players (2022)

12. Company Profiles (Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)

  • 12.1. Thermo Fisher Scientific, Inc.
  • 12.2. Merck KgaA
  • 12.3. Eppendorf SE
  • 12.4. Agilent Technologies, Inc.
  • 12.5. Sartorius AG
  • 12.6. Danaher Corporation
  • 12.7. Waters Corporation
  • 12.8. Shimadzu Corporation
  • 12.9. Solaris Biotechnology Srl
  • 12.10. Infors AG

(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)

13. Appendix

  • 13.1. Available Customization
  • 13.2. Related Reports

LIST OF TABLES

  • Table 1 Global Antibody Production Market, By Product, 2022-2031 (USD Million)
  • Table 2 Global Antibody Production Instruments Market, By Type, 2022-2031 (USD Million)
  • Table 3 Global Antibody Production Instruments Market, By Country/Region, 2022-2031 (USD Million)
  • Table 4 Global Bioreactors Market for Antibody Production, By Type, 2022-2031 (USD Million)
  • Table 5 Global Bioreactors Market for Antibody Production, By Country/Region, 2022-2031 (USD Million)
  • Table 6 Global Reusable Bioreactors Market for Antibody Production, By Country/Region, 2022-2031 (USD Million)
  • Table 7 Global Single-use Bioreactors Market for Antibody Production, By Country/Region, 2022-2031 (USD Million)
  • Table 8 Global Filtration Systems Market for Antibody Production, By Country/Region, 2022-2031 (USD Million)
  • Table 9 Global Chromatography Systems Market for Antibody Production, By Country/Region, 2022-2031 (USD Million)
  • Table 10 Global Other Instruments Market for Antibody Production, By Country/Region, 2022-2031 (USD Million)
  • Table 11 Global Antibody Production Consumables Market, By Type, 2022-2031 (USD Million)
  • Table 12 Global Antibody Production Consumables Market, By Country/Region, 2022-2031 (USD Million)
  • Table 13 Global Cell Lines & Media Market, By Country/Region, 2022-2031 (USD Million)
  • Table 14 Global Buffers & Reagents Market, By Country/Region, 2022-2031 (USD Million)
  • Table 15 Global Chromatography Columns & Resins Market, By Country/Region, 2022-2031 (USD Million)
  • Table 16 Global Other Antibody Production Consumables Market, By Country/Region, 2022-2031 (USD Million)
  • Table 17 Global Antibody Production Software Market, By Country/Region, 2022-2031 (USD Million)
  • Table 18 Global Antibody Production Market, By Antibody Type, 2022-2031 (USD Million)
  • Table 19 Global Monoclonal Antibodies Production Market, By Country/Region, 2022-2031 (USD Million)
  • Table 20 Global Polyclonal Antibodies Production Market, By Country/Region, 2022-2031 (USD Million)
  • Table 21 Global Recombinant Antibodies Production Market, By Country/Region, 2022-2031 (USD Million)
  • Table 22 Global Antibody Production Market, By Source, 2022-2031 (USD Million)
  • Table 23 Global Antibody Production Market for Mice, By Country/Region, 2022-2031 (USD Million)
  • Table 24 Global Antibody Production Market for Rabbit, By Country/Region, 2022-2031 (USD Million)
  • Table 25 Global Antibody Production Market for Other Sources, By Country/Region, 2022-2031 (USD Million)
  • Table 26 Global Antibody Production Market, By Process, 2022-2031 (USD Million)
  • Table 27 Global Antibody Production Market for Downstream Process, By Country/Region, 2022-2031 (USD Million)
  • Table 28 Global Antibody Production Market for Upstream Process, By Country/Region, 2022-2031 (USD Million)
  • Table 29 Global Antibody Production Market, By End User, 2022-2031 (USD Million)
  • Table 30 Global Antibody Production Market for Pharmaceutical & Biotechnology Companies, By Country/Region, 2022-2031 (USD Million)
  • Table 31 Global Antibody Production Market for CROs & CDMOs, By Country/Region, 2022-2031 (USD Million)
  • Table 32 Global Antibody Production Market for Academic & Research Institutes, By Country/Region, 2022-2031 (USD Million)
  • Table 33 Global Antibody Production Market, By Country/Region, 2022-2031 (USD Million)
  • Table 34 North America: Antibody Production Market, By Country, 2022-2031 (USD Million)
  • Table 35 North America: Antibody Production Market, By Product, 2022-2031 (USD Million)
  • Table 36 North America: Antibody Production Instruments Market, By Type, 2022-2031 (USD Million)
  • Table 37 North America: Bioreactors for Antibody Production Market, By Type, 2022-2031 (USD Million)
  • Table 38 North America: Antibody Production Consumables Market, By Type, 2022-2031 (USD Million)
  • Table 39 North America: Antibody Production Market, By Antibody Type, 2022-2031 (USD Million)
  • Table 40 North America: Antibody Production Market, By Source, 2022-2031 (USD Million)
  • Table 41 North America: Antibody Production Market, By Process, 2022-2031 (USD Million)
  • Table 42 North America: Antibody Production Market, By End User, 2022-2031 (USD Million)
  • Table 43 U.S.: Antibody Production Market, By Product, 2022-2031 (USD Million)
  • Table 44 U.S.: Antibody Production Instruments Market, By Type, 2022-2031 (USD Million)
  • Table 45 U.S.: Bioreactors for Antibody Production Market, By Type, 2022-2031 (USD Million)
  • Table 46 U.S.: Antibody Production Consumables Market, By Type, 2022-2031 (USD Million)
  • Table 47 U.S.: Antibody Production Market, By Antibody Type, 2022-2031 (USD Million)
  • Table 48 U.S.: Antibody Production Market, By Source, 2022-2031 (USD Million)
  • Table 49 U.S.: Antibody Production Market, By Process, 2022-2031 (USD Million)
  • Table 50 U.S.: Antibody Production Market, By End User, 2022-2031 (USD Million)
  • Table 51 Canada: Antibody Production Market, By Product, 2022-2031 (USD Million)
  • Table 52 Canada: Antibody Production Instruments Market, By Type, 2022-2031 (USD Million)
  • Table 53 Canada: Bioreactors for Antibody Production Market, By Type, 2022-2031 (USD Million)
  • Table 54 Canada: Antibody Production Consumables Market, By Type, 2022-2031 (USD Million)
  • Table 55 Canada: Antibody Production Market, By Antibody Type, 2022-2031 (USD Million)
  • Table 56 Canada: Antibody Production Market, By Source, 2022-2031 (USD Million)
  • Table 57 Canada: Antibody Production Market, By Process, 2022-2031 (USD Million)
  • Table 58 Canada: Antibody Production Market, By End User, 2022-2031 (USD Million)
  • Table 59 Europe: Antibody Production Market, By Country, 2022-2031 (USD Million)
  • Table 60 Europe: Antibody Production Market, By Product, 2022-2031 (USD Million)
  • Table 61 Europe: Antibody Production Instruments Market, By Type, 2022-2031 (USD Million)
  • Table 62 Europe: Bioreactors for Antibody Production Market, By Type, 2022-2031 (USD Million)
  • Table 63 Europe: Antibody Production Consumables Market, By Type, 2022-2031 (USD Million)
  • Table 64 Europe: Antibody Production Market, By Antibody Type, 2022-2031 (USD Million)
  • Table 65 Europe: Antibody Production Market, By Source, 2022-2031 (USD Million)
  • Table 66 Europe: Antibody Production Market, By Process, 2022-2031 (USD Million)
  • Table 67 Europe: Antibody Production Market, By End User, 2022-2031 (USD Million)
  • Table 68 Germany: Antibody Production Market, By Product, 2022-2031 (USD Million)
  • Table 69 Germany: Antibody Production Instruments Market, By Type, 2022-2031 (USD Million)
  • Table 70 Germany: Bioreactors for Antibody Production Market, By Type, 2022-2031 (USD Million)
  • Table 71 Germany: Antibody Production Consumables Market, By Type, 2022-2031 (USD Million)
  • Table 72 Germany: Antibody Production Market, By Antibody Type, 2022-2031 (USD Million)
  • Table 73 Germany: Antibody Production Market, By Source, 2022-2031 (USD Million)
  • Table 74 Germany: Antibody Production Market, By Process, 2022-2031 (USD Million)
  • Table 75 Germany: Antibody Production Market, By End User, 2022-2031 (USD Million)
  • Table 76 France: Antibody Production Market, By Product, 2022-2031 (USD Million)
  • Table 77 France: Antibody Production Instruments Market, By Type, 2022-2031 (USD Million)
  • Table 78 France: Bioreactors for Antibody Production Market, By Type, 2022-2031 (USD Million)
  • Table 79 France: Antibody Production Consumables Market, By Type, 2022-2031 (USD Million)
  • Table 80 France: Antibody Production Market, By Antibody Type, 2022-2031 (USD Million)
  • Table 81 France: Antibody Production Market, By Source, 2022-2031 (USD Million)
  • Table 82 France: Antibody Production Market, By Process, 2022-2031 (USD Million)
  • Table 83 France: Antibody Production Market, By End User, 2022-2031 (USD Million)
  • Table 84 U.K.: Antibody Production Market, By Product, 2022-2031 (USD Million)
  • Table 85 U.K.: Antibody Production Instruments Market, By Type, 2022-2031 (USD Million)
  • Table 86 U.K.: Bioreactors for Antibody Production Market, By Type, 2022-2031 (USD Million)
  • Table 87 U.K.: Antibody Production Consumables Market, By Type, 2022-2031 (USD Million)
  • Table 88 U.K.: Antibody Production Market, By Antibody Type, 2022-2031 (USD Million)
  • Table 89 U.K.: Antibody Production Market, By Source, 2022-2031 (USD Million)
  • Table 90 U.K.: Antibody Production Market, By Process, 2022-2031 (USD Million)
  • Table 91 U.K.: Antibody Production Market, By End User, 2022-2031 (USD Million)
  • Table 92 Spain: Antibody Production Market, By Product, 2022-2031 (USD Million)
  • Table 93 Spain: Antibody Production Instruments Market, By Type, 2022-2031 (USD Million)
  • Table 94 Spain: Bioreactors for Antibody Production Market, By Type, 2022-2031 (USD Million)
  • Table 95 Spain: Antibody Production Consumables Market, By Type, 2022-2031 (USD Million)
  • Table 96 Spain: Antibody Production Market, By Antibody Type, 2022-2031 (USD Million)
  • Table 97 Spain: Antibody Production Market, By Source, 2022-2031 (USD Million)
  • Table 98 Spain: Antibody Production Market, By Process, 2022-2031 (USD Million)
  • Table 99 Spain: Antibody Production Market, By End User, 2022-2031 (USD Million)
  • Table 100 Italy: Antibody Production Market, By Product, 2022-2031 (USD Million)
  • Table 101 Italy: Antibody Production Instruments Market, By Type, 2022-2031 (USD Million)
  • Table 102 Italy: Bioreactors for Antibody Production Market, By Type, 2022-2031 (USD Million)
  • Table 103 Italy: Antibody Production Consumables Market, By Type, 2022-2031 (USD Million)
  • Table 104 Italy: Antibody Production Market, By Antibody Type, 2022-2031 (USD Million)
  • Table 105 Italy: Antibody Production Market, By Source, 2022-2031 (USD Million)
  • Table 106 Italy: Antibody Production Market, By Process, 2022-2031 (USD Million)
  • Table 107 Italy: Antibody Production Market, By End User, 2022-2031 (USD Million)
  • Table 108 RoE: Antibody Production Market, By Product, 2022-2031 (USD Million)
  • Table 109 RoE: Antibody Production Instruments Market, By Type, 2022-2031 (USD Million)
  • Table 110 RoE: Bioreactors for Antibody Production Market, By Type, 2022-2031 (USD Million)
  • Table 111 RoE: Antibody Production Consumables Market, By Type, 2022-2031 (USD Million)
  • Table 112 RoE: Antibody Production Market, By Antibody Type, 2022-2031 (USD Million)
  • Table 113 RoE: Antibody Production Market, By Source, 2022-2031 (USD Million)
  • Table 114 RoE: Antibody Production Market, By Process, 2022-2031 (USD Million)
  • Table 115 RoE: Antibody Production Market, By End User, 2022-2031 (USD Million)
  • Table 116 Asia-Pacific: Antibody Production Market, By Country/Region, 2022-2031 (USD Million)
  • Table 117 Asia-Pacific: Antibody Production Market, By Product, 2022-2031 (USD Million)
  • Table 118 Asia-Pacific: Antibody Production Instruments Market, By Type, 2022-2031 (USD Million)
  • Table 119 Asia-Pacific: Bioreactors for Antibody Production Market, By Type, 2022-2031 (USD Million)
  • Table 120 Asia-Pacific: Antibody Production Consumables Market, By Type, 2022-2031 (USD Million)
  • Table 121 Asia-Pacific: Antibody Production Market, By Antibody Type, 2022-2031 (USD Million)
  • Table 122 Asia-Pacific: Antibody Production Market, By Source, 2022-2031 (USD Million)
  • Table 123 Asia-Pacific: Antibody Production Market, By Process, 2022-2031 (USD Million)
  • Table 124 Asia-Pacific: Antibody Production Market, By End User, 2022-2031 (USD Million)
  • Table 125 China: Antibody Production Market, By Product, 2022-2031 (USD Million)
  • Table 126 China: Antibody Production Instruments Market, By Type, 2022-2031 (USD Million)
  • Table 127 China: Bioreactors for Antibody Production Market, By Type, 2022-2031 (USD Million)
  • Table 128 China: Antibody Production Consumables Market, By Type, 2022-2031 (USD Million)
  • Table 129 China: Antibody Production Market, By Antibody Type, 2022-2031 (USD Million)
  • Table 130 China: Antibody Production Market, By Source, 2022-2031 (USD Million)
  • Table 131 China: Antibody Production Market, By Process, 2022-2031 (USD Million)
  • Table 132 China: Antibody Production Market, By End User, 2022-2031 (USD Million)
  • Table 133 Japan: Antibody Production Market, By Product, 2022-2031 (USD Million)
  • Table 134 Japan: Antibody Production Instruments Market, By Type, 2022-2031 (USD Million)
  • Table 135 Japan: Bioreactors for Antibody Production Market, By Type, 2022-2031 (USD Million)
  • Table 136 Japan: Antibody Production Consumables Market, By Type, 2022-2031 (USD Million)
  • Table 137 Japan: Antibody Production Market, By Antibody Type, 2022-2031 (USD Million)
  • Table 138 Japan: Antibody Production Market, By Source, 2022-2031 (USD Million)
  • Table 139 Japan: Antibody Production Market, By Process, 2022-2031 (USD Million)
  • Table 140 Japan: Antibody Production Market, By End User, 2022-2031 (USD Million)
  • Table 141 RoAPAC: Antibody Production Market, By Product, 2022-2031 (USD Million)
  • Table 142 RoAPAC: Antibody Production Instruments Market, By Type, 2022-2031 (USD Million)
  • Table 143 RoAPAC: Bioreactors for Antibody Production Market, By Type, 2022-2031 (USD Million)
  • Table 144 RoAPAC: Antibody Production Consumables Market, By Type, 2022-2031 (USD Million)
  • Table 145 RoAPAC: Antibody Production Market, By Antibody Type, 2022-2031 (USD Million)
  • Table 146 RoAPAC: Antibody Production Market, By Source, 2022-2031 (USD Million)
  • Table 147 RoAPAC: Antibody Production Market, By Process, 2022-2031 (USD Million)
  • Table 148 RoAPAC: Antibody Production Market, By End User, 2022-2031 (USD Million)
  • Table 149 Latin America: Antibody Production Market, By Country, 2022-2031 (USD Million)
  • Table 150 Latin America: Antibody Production Market, By Product, 2022-2031 (USD Million)
  • Table 151 Latin America: Antibody Production Instruments Market, By Type, 2022-2031 (USD Million)
  • Table 152 Latin America: Bioreactors for Antibody Production Market, By Type, 2022-2031 (USD Million)
  • Table 153 Latin America: Antibody Production Consumables Market, By Type, 2022-2031 (USD Million)
  • Table 154 Latin America: Antibody Production Market, By Antibody Type, 2022-2031 (USD Million)
  • Table 155 Latin America: Antibody Production Market, By Source, 2022-2031 (USD Million)
  • Table 156 Latin America: Antibody Production Market, By Process, 2022-2031 (USD Million)
  • Table 157 Latin America: Antibody Production Market, By End User, 2022-2031 (USD Million)
  • Table 158 Brazil: Antibody Production Market, By Product, 2022-2031 (USD Million)
  • Table 159 Brazil: Antibody Production Instruments Market, By Type, 2022-2031 (USD Million)
  • Table 160 Brazil: Bioreactors for Antibody Production Market, By Type, 2022-2031 (USD Million)
  • Table 161 Brazil: Antibody Production Consumables Market, By Type, 2022-2031 (USD Million)
  • Table 162 Brazil: Antibody Production Market, By Antibody Type, 2022-2031 (USD Million)
  • Table 163 Brazil: Antibody Production Market, By Source, 2022-2031 (USD Million)
  • Table 164 Brazil: Antibody Production Market, By Process, 2022-2031 (USD Million)
  • Table 165 Brazil: Antibody Production Market, By End User, 2022-2031 (USD Million)
  • Table 166 Mexico: Antibody Production Market, By Product, 2022-2031 (USD Million)
  • Table 167 Mexico: Antibody Production Instruments Market, By Type, 2022-2031 (USD Million)
  • Table 168 Mexico: Bioreactors for Antibody Production Market, By Type, 2022-2031 (USD Million)
  • Table 169 Mexico: Antibody Production Consumables Market, By Type, 2022-2031 (USD Million)
  • Table 170 Mexico: Antibody Production Market, By Antibody Type, 2022-2031 (USD Million)
  • Table 171 Mexico: Antibody Production Market, By Source, 2022-2031 (USD Million)
  • Table 172 Mexico: Antibody Production Market, By Process, 2022-2031 (USD Million)
  • Table 173 Mexico: Antibody Production Market, By End User, 2022-2031 (USD Million)
  • Table 174 RoLATAM: Antibody Production Market, By Product, 2022-2031 (USD Million)
  • Table 175 RoLATAM: Antibody Production Instruments Market, By Type, 2022-2031 (USD Million)
  • Table 176 RoLATAM: Bioreactors for Antibody Production Market, By Type, 2022-2031 (USD Million)
  • Table 177 RoLATAM: Antibody Production Consumables Market, By Type, 2022-2031 (USD Million)
  • Table 178 RoLATAM: Antibody Production Market, By Antibody Type, 2022-2031 (USD Million)
  • Table 179 RoLATAM: Antibody Production Market, By Source, 2022-2031 (USD Million)
  • Table 180 RoLATAM: Antibody Production Market, By Process, 2022-2031 (USD Million)
  • Table 181 RoLATAM: Antibody Production Market, By End User, 2022-2031 (USD Million)
  • Table 182 Middle East & Africa: Antibody Production Market, By Product, 2022-2031 (USD Million)
  • Table 183 Middle East & Africa: Antibody Production Instruments Market, By Type, 2022-2031 (USD Million)
  • Table 184 Middle East & Africa: Bioreactors for Antibody Production Market, By Type, 2022-2031 (USD Million)
  • Table 185 Middle East & Africa: Antibody Production Consumables Market, By Type, 2022-2031 (USD Million)
  • Table 186 Middle East & Africa: Antibody Production Market, By Antibody Type, 2022-2031 (USD Million)
  • Table 187 Middle East & Africa: Antibody Production Market, By Source, 2022-2031 (USD Million)
  • Table 188 Middle East & Africa: Antibody Production Market, By Process, 2022-2031 (USD Million)
  • Table 189 Middle East & Africa: Antibody Production Market, By End User, 2022-2031 (USD Million)
  • Table 190 Recent Developments, By Company, 2020-2023

LIST OF FIGURES

  • Figure 1 Research Process
  • Figure 2 Secondary Sources Referenced for This Study
  • Figure 3 Primary Research Techniques
  • Figure 4 Key Executives Interviewed
  • Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
  • Figure 6 Market Sizing and Growth Forecast Approach
  • Figure 7 Global Antibody Production Market, By Product, 2024 Vs. 2031 (USD Million)
  • Figure 8 Global Antibody Production Market, By Antibody Type, 2024 Vs. 2031 (USD Million)
  • Figure 9 Global Antibody Production Market, By Source, 2024 Vs. 2031 (USD Million)
  • Figure 10 Global Antibody Production Market, By Process, 2024 Vs. 2031 (USD Million)
  • Figure 11 Global Antibody Production Market, By End User, 2024 Vs. 2031 (USD Million)
  • Figure 12 Global Antibody Production Market, By Geography
  • Figure 13 Impact Analysis of Market Dynamics
  • Figure 14 Global Antibody Production Market, By Product, 2024 Vs. 2031 (USD Million)
  • Figure 15 Global Antibody Production Market, By Antibody Type, 2024 Vs. 2031 (USD Million)
  • Figure 16 Global Antibody Production Market, By Source, 2024 Vs. 2031 (USD Million)
  • Figure 17 Global Antibody Production Market, By Process, 2024 Vs. 2031 (USD Million)
  • Figure 18 Global Antibody Production Market, By End User, 2024 Vs. 2031 (USD Million)
  • Figure 19 Global Antibody Production Market, By Geography, 2024 Vs. 2031 (USD Million)
  • Figure 20 North America: Antibody Production Market Snapshot
  • Figure 21 Europe: Antibody Production Market Snapshot
  • Figure 22 Asia-Pacific: Antibody Production Market Snapshot
  • Figure 23 Latin America: Antibody Production Market Snapshot
  • Figure 24 Key Growth Strategies Adopted by Leading Players (2022-2024)
  • Figure 25 Antibody Production Market: Competitive Benchmarking, By Product
  • Figure 26 Antibody Production Market: Competitive Benchmarking, By Region
  • Figure 27 Competitive Dashboard Antibody Production Market
  • Figure 28 Global Antibody Production Market Share Analysis, By Key Players, 2024
  • Figure 29 Thermo Fisher Scientific, Inc.: Financial Overview (2024)
  • Figure 30 Merck KgaA.: Financial Overview (2024)
  • Figure 31 Eppendorf SE: Financial Overview (2024)
  • Figure 32 Agilent Technologies, Inc.: Financial Overview (2024)
  • Figure 33 Sartorius AG: Financial Overview (2024)
  • Figure 34 Danaher Corporation: Financial Overview (2024)
  • Figure 35 Waters Corporation: Financial Overview (2024)
  • Figure 36 Shimadzu Corporation: Financial Overview (2024)